Please provide your email address to receive an email when new articles are posted on . Somapacitan-beco improved multiple growth-related endpoints for adolescents with four types of short stature.

Please provide your email address to receive an email when new articles are posted on . Children receiving once-weekly somapacitan had a mean height velocity increase of 6.6 cm to 7.7 cm at 4 years.